Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

1,000 Robotic Surgeries: Karmanos Urologic Oncologist Celebrates Milestone

For 30 years, Michael Cher, M.D. , urologic oncologist, chief of Urology and member of the Genitourinary Oncology Multidisciplinary Team (MDT), ha...

Read More

‘Y’all Saved My Life’: How a Man’s Decision to Quit Smoking Led to the Shocking Diagnosis of Lung Cancer

“If you care about your life and your family members, get the screenings because they are important." Lung cancer is still the leading cause of ca...

Read More

Karmanos Cancer Institute Recognizes Pancreatic Cancer Awareness Month, the Third Deadliest Cancer

The Barbara Ann Karmanos Cancer Institute , along with cancer centers and other organizations nationwide, recognizes November as Pancreatic Cancer...

Read More
News

WWJ | Karmanos Psychologist on Emotional Impact of Breast Cancer Diagnosis

Listen Now

WWJ | ‘Houses with Roofs Caved In’: Karmanos Surgeon Explains Stage 0 Breast Cancer (DCIS)

Listen Now

WWJ | Treatment Plans, Clinical Trials and Second Opinions: Navigating a Breast Cancer Diagnosis

Listen Now